Cold & Cough Remedies (Pharmacies) - Algeria

  • Algeria
  • Revenue in the Cold & Cough Remedies market is projected to reach US$110.20m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.20%, resulting in a market volume of US$135.40m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.38 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Algeria is experiencing steady growth due to several factors.

Customer preferences:
Customers in Algeria have a strong preference for over-the-counter cold and cough remedies, which can be easily purchased at pharmacies without a prescription. This preference is driven by the convenience and accessibility of these products, as well as the perception that they provide quick relief from cold and cough symptoms. Additionally, customers in Algeria often rely on traditional remedies and herbal medicines to treat cold and cough symptoms, leading to a demand for products that combine both traditional and modern medicine.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Algeria is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to synthetic medications. As a result, there is a growing market for cold and cough remedies that are made from natural ingredients and have fewer side effects. Another trend in the market is the rising popularity of combination products. Customers in Algeria prefer products that provide relief from multiple symptoms, such as cough, congestion, and sore throat. Combination products that offer a comprehensive solution to cold and cough symptoms are gaining traction in the market.

Local special circumstances:
Algeria has a high incidence of cold and cough due to its climate and environmental conditions. The country experiences cold winters and dusty summers, which can contribute to respiratory infections and allergies. As a result, there is a constant demand for cold and cough remedies throughout the year. Furthermore, the Algerian government has implemented policies to promote the use of locally manufactured pharmaceutical products. This has led to an increase in the production of cold and cough remedies within the country, creating a favorable market environment for local manufacturers.

Underlying macroeconomic factors:
The growing middle class in Algeria is driving the demand for cold and cough remedies. As disposable incomes increase, more customers are able to afford these products, leading to a higher demand in the market. Additionally, the country's population is growing, which further contributes to the increasing demand for cold and cough remedies. Furthermore, the healthcare sector in Algeria is undergoing significant development, with increased investment in healthcare infrastructure and services. This has led to improved access to healthcare facilities and increased awareness about the importance of treating cold and cough symptoms. As a result, more customers are seeking out cold and cough remedies at pharmacies, driving the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Algeria is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, local special circumstances such as the climate and government policies, and underlying macroeconomic factors such as the growing middle class and improved healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)